As ccRCC is well elucidated for its VHL/HIF dysregulation and downstream signal abnormalities (55), we may speculate that the VHL/HIF pathway is the key upstream regulator of CD146 in ccRCC, which needs further verification. The gene discussed is MCAM; the disease is nonpapillary renal cell carcinoma.